Evaluation of single dose Pregabalin vs. placebo in reducing post– Photorefractive Keratectomy pain

AuthorMansour Chubsazen
AuthorFarid Daneshgaren
AuthorNasrin Amiri Fard‎en
AuthorTayebeh Kazerooni‎en
AuthorEbrahim Ghaderi‎en
Issued Date2014-12-21en
AbstractBackground: Today, Photorefractive keratectomy (PRK) is one of the most common methods of eye surgery and the most important problem of patient and medical team that are confronted about this surgery is pain. The aim of this study was to determine the efficacy of Pregabalin for reducing post–photorefractive keratectomy (PRK) pain.Methods: This study was done as a double blind clinical trial. Patients were divided in two groups (40 patients in each group) as case and control and 30 minute before surgery 150 mg Pregabalin and placebo were prescribed for case and control groups, respectively. In 6, 12 and 24 hours after surgery, pain was measured by Visual Analog Scale (VAS).Results: The results of this study were showed pain score in 6 and 12 hours after surgery in Pregabalin group was significant lower than control (P3 and needs to Acetaminophen; whereas in control group 33 patients (82.5%) had VAS score >3 (Pen
DOIhttps://doi.org/en
KeywordPhotorefractive keratectomyen
KeywordPregabalinen
Keywordpainen
KeywordVisual Analog Scaleen
PublisherBrieflandsen
TitleEvaluation of single dose Pregabalin vs. placebo in reducing post– Photorefractive Keratectomy painen
TypeResearch Articleen

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
82116.pdf
Size:
959.98 KB
Format:
Adobe Portable Document Format
Description:
Article/s PDF